Drug Search Results
More Filters [+]

Mupirocin

Alternative Names: mupirocin, bactroban, centany, pirnuo, nusurgepak surgical prep/carepak
Latest Update: 2024-09-11
Latest Update Note: Clinical Trial Update

Product Description

Mupirocin, an antibiotic, is used to treat impetigo as well as other skin infections caused by bacteria. It is not effective against fungal or viral infections. (Sourced from: https://medlineplus.gov/druginfo/meds/a688004.html)

Mechanisms of Action: Protein Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Nasal

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Lebanon | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Impetigo

Known Adverse Events: Pain Unspecified

Company: Helperby Thearapeutics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mupirocin

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Impetigo

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20230116

P3

Recruiting

Impetigo

None

Recent News Events